Xiao Zheng Selected Research

Neoplasm Metastasis (Metastasis)

4/2024	Microwave ablation combined with PD-L1 blockade synergistically promotes Cxcl9-mediated antitumor immunity.
2/2024	Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
12/2023	Interleukin-1 receptor antagonist: An alternative therapy for cancer treatment.
10/2023	Repressed Blautia-acetate immunological axis underlies breast cancer progression promoted by chronic stress.
1/2023	PRMT5 facilitates angiogenesis and EMT via HIF-1α/VEGFR/Akt signaling axis in lung cancer.
1/2023	Dynamic tagging to drive arginine nano-assembly to metabolically potentiate immune checkpoint blockade therapy.
10/2022	Tumor Microenvironment, Clinical Features, and Advances in Therapy for Bone Metastasis in Gastric Cancer.
10/2022	IL1R2 promotes tumor progression via JAK2/STAT3 pathway in human clear cell renal cell carcinoma.
1/2022	Targeting the Negative Feedback of Adenosine-A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy.
1/2022	Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Zheng Research Topics

Disease

117	Neoplasms (Cancer) 04/2024 - 01/2003
33	Neoplasm Metastasis (Metastasis) 04/2024 - 03/2003
18	Stomach Neoplasms (Stomach Cancer) 10/2022 - 05/2010
15	Breast Neoplasms (Breast Cancer) 02/2024 - 05/2003
14	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 08/2012
13	Inflammation (Inflammations) 12/2023 - 08/2011
13	Infections 06/2022 - 12/2013
11	Liver Neoplasms (Liver Cancer) 01/2024 - 06/2015
11	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 01/2014
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 05/2013
10	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 02/2011
10	Carcinogenesis 12/2023 - 01/2014
9	Esophageal Squamous Cell Carcinoma 01/2023 - 10/2016
8	Lung Neoplasms (Lung Cancer) 08/2023 - 10/2014
7	Colonic Neoplasms (Colon Cancer) 12/2023 - 12/2016
6	Ovarian Neoplasms (Ovarian Cancer) 03/2021 - 05/2015
5	Hypoxia (Hypoxemia) 05/2024 - 01/2017
5	Glioblastoma (Glioblastoma Multiforme) 09/2005 - 01/2003
4	Obesity 01/2023 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 02/2022 - 01/2013
4	Insulin Resistance 01/2020 - 01/2016
4	Human Influenza (Influenza) 11/2019 - 12/2014
4	Congenital Hypothyroidism (Cretinism) 07/2017 - 01/2016
3	Carcinoma (Carcinomatosis) 11/2023 - 03/2003
3	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023 - 01/2021
3	Adenocarcinoma of Lung 08/2023 - 10/2014
3	Wounds and Injuries (Trauma) 06/2022 - 01/2013
3	Lymphatic Metastasis 12/2021 - 10/2017
3	Ischemia 11/2021 - 08/2019
3	Colitis 12/2020 - 01/2017
3	Glioma (Gliomas) 02/2018 - 01/2003
2	Gliosis 11/2023 - 11/2023
2	Reperfusion Injury 11/2023 - 08/2019
2	Huntington Disease (Huntington's Disease) 01/2023 - 12/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2022 - 11/2015

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2003
13	MicroRNAs (MicroRNA)IBA 12/2023 - 01/2011
12	Immune Checkpoint InhibitorsIBA 04/2024 - 11/2015
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
10	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
10	BerberineIBA 03/2021 - 01/2017
9	Messenger RNA (mRNA)IBA 12/2022 - 01/2012
7	Silicon Dioxide (Silica)FDA LinkGeneric 04/2022 - 01/2015
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2004
6	AntigensIBA 02/2024 - 10/2021
6	Small Cytoplasmic RNAIBA 01/2024 - 01/2022
6	Circular RNAIBA 01/2023 - 01/2019
6	CytokinesIBA 10/2022 - 12/2010
5	Therapeutic UsesIBA 11/2023 - 01/2019
5	VaccinesIBA 09/2023 - 07/2021
5	LipopolysaccharidesIBA 06/2022 - 08/2011
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 02/2011
4	LigandsIBA 04/2024 - 01/2018
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024 - 01/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 03/2012
4	cordycepinIBA 12/2023 - 01/2023
4	Peptides (Polypeptides)IBA 11/2023 - 01/2019
4	6-methyladenineIBA 01/2023 - 01/2022
4	Antiviral Agents (Antivirals)IBA 06/2022 - 10/2020
4	AlkaloidsIBA 02/2022 - 01/2017
4	Long Noncoding RNAIBA 01/2022 - 01/2019
3	ErbB Receptors (EGF Receptor)IBA 05/2024 - 10/2014
3	EnzymesIBA 05/2024 - 06/2014
3	AntibodiesIBA 04/2024 - 11/2015
3	DNA (Deoxyribonucleic Acid)IBA 05/2023 - 07/2019
3	Neoplasm Antigens (Tumor Antigens)IBA 02/2023 - 10/2021
3	N-methyladenosineIBA 01/2023 - 01/2022
3	Carrier Proteins (Binding Protein)IBA 01/2023 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 12/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2016
3	Dual OxidasesIBA 07/2017 - 01/2016
3	Cisplatin (Platino)FDA LinkGeneric 09/2015 - 12/2004
3	Phosphotransferases (Kinase)IBA 10/2014 - 12/2013
3	Carmustine (FIVB)FDA Link 09/2005 - 07/2004
2	Cetuximab (Erbitux)FDA Link 05/2024 - 09/2015
2	B7-H1 AntigenIBA 04/2024 - 01/2017
2	ChemokinesIBA 04/2024 - 12/2017
2	Arginine (L-Arginine)FDA Link 01/2024 - 01/2023
2	Interleukin-1 (Interleukin 1)IBA 12/2023 - 10/2022
2	Estrogen ReceptorsIBA 11/2023 - 11/2013
2	NanovaccinesIBA 09/2023 - 10/2021
2	HydrogelsIBA 09/2023 - 06/2022
2	CurcuminIBA 09/2023 - 01/2021
2	Cancer VaccinesIBA 09/2023 - 01/2022
2	Thyroid HormonesIBA 06/2023 - 11/2016
2	InflammasomesIBA 05/2023 - 01/2019
2	PowdersIBA 04/2023 - 01/2018
2	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2023 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2012

Therapy/Procedure

56	Therapeutics 05/2024 - 01/2003
27	Immunotherapy 04/2024 - 03/2013
27	Drug Therapy (Chemotherapy) 12/2021 - 05/2003
14	Radiotherapy 01/2023 - 03/2003
7	Neoadjuvant Therapy 01/2023 - 01/2018
7	Precision Medicine 04/2022 - 06/2015
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2023 - 01/2017
6	Chemoradiotherapy 01/2022 - 09/2015
3	Oral Administration 03/2020 - 05/2015
2	Combination Drug Therapy (Combination Chemotherapy) 04/2024 - 05/2003
2	Radiofrequency Ablation 02/2023 - 03/2016